These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1870751)

  • 1. Urine cytology as a screening method for transitional-cell carcinoma in dialysis patients with analgesic nephropathy.
    Veltman GA; Bosch FH; van der Plas-Cats MB; van Leusen R
    Nephrol Dial Transplant; 1991; 6(5):346-8. PubMed ID: 1870751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High mortality from urothelial carcinoma despite regular tumor screening in patients with analgesic nephropathy after renal transplantation.
    Kliem V; Thon W; Krautzig S; Kolditz M; Behrend M; Pichlmayr R; Koch KM; Frei U; Brunkhorst R
    Transpl Int; 1996; 9(3):231-5. PubMed ID: 8723192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine cytology in the follow-up of patients with transitional cell carcinoma of the urinary bladder: is that enough as a single method?
    Raica M; Miclea F; Ioiart I; Minciu R; Drăgan P
    Rom J Morphol Embryol; 1998; 44(1-4):173-8. PubMed ID: 15678859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transitional cell carcinoma in renal transplant recipients: the influence of compound analgesics.
    Swindle P; Falk M; Rigby R; Petrie J; Hawley C; Nicol D
    Br J Urol; 1998 Feb; 81(2):229-33. PubMed ID: 9488064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract.
    Konety BR; Metro MJ; Melham MF; Salup RR
    Urol Int; 1999; 62(1):26-30. PubMed ID: 10436427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic-associated nephropathy and transitional cell carcinoma of the urinary tract.
    Gonwa TA; Corbett WT; Schey HM; Buckalew VM
    Ann Intern Med; 1980 Aug; 93(2):249-52. PubMed ID: 7406375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta 2-microglobulin excretion and urinary cytology in analgesic nephropathy.
    Russ GR; Horgan BA; Mathew TH; Brown H; Mills L; Kirkland JA
    Clin Nephrol; 1982 Sep; 18(3):148-53. PubMed ID: 6183039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic nephropathy and urinary-tract carcinoma.
    Gonwa TA; Buckalew VM; Corbett WT
    Ann Intern Med; 1979 Mar; 90(3):432-3. PubMed ID: 426416
    [No Abstract]   [Full Text] [Related]  

  • 10. [Urinary NMP22 as a new marker in patients with transitional cell carcinoma].
    Muzzonigro G; Minardi D; Galosi AB; Recchioni A; De Sio G; Polito M
    Arch Ital Urol Androl; 1999 Jun; 71(3):171-7. PubMed ID: 10431409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine cytology findings in analgesic nephropathy.
    Jackson B; Kirkland JA; Lawrence JR; Narayan AS; Brown HE; Mills LR
    J Urol; 1978 Aug; 120(2):145-7. PubMed ID: 671620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phenacetin abuse IV. Are cytological urine studies successful and usable in the prevention of tumors in phenacetin abusers?].
    Dalquen P; Fasel J; Mihatsch MJ; Rist M; Rutishauser G
    Schweiz Med Wochenschr; 1980 Feb; 110(8):302-6. PubMed ID: 7367850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer.
    Sadek S; Soloway MS; Hook S; Civantos F
    J Urol; 1999 Jan; 161(1):77-9; discussion 79-80. PubMed ID: 10037373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic nephroureterectomy to exclude upper urinary tract malignancy associated with analgesic nephropathy.
    Doehn C; Fornara P; Fricke L; Jocham D
    J Endourol; 2001 Oct; 15(8):809-14. PubMed ID: 11724120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of analgetics nephropathy].
    Elseviers MM; De Broe ME
    Arch Belg; 1989; 47(1-4):77-80. PubMed ID: 2610578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercalcaemia as a manifestation of malignant urothelial change in analgesic nephropathy.
    Derbyshire ND; Asscher AW; Matthews PN
    Nephron; 1989; 52(1):79-80. PubMed ID: 2710270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urinary cytology of transitional-cell carcinoma].
    Piazza G; Galia A; Cosentino A; Grasso G
    Pathologica; 1995 Apr; 87(2):146-7. PubMed ID: 8532407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical value of urinary cytology: 12 years of experience with 615 patients.
    Maier U; Simak R; Neuhold N
    J Clin Pathol; 1995 Apr; 48(4):314-7. PubMed ID: 7615848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phenacetin abuse. VII: Urinary tract tumors in dialysis patients and patients with kidney grafts].
    Mihatsch MJ; Brunner FP; Korteweg E; Rist M; Dalquen P; Thiel G
    Schweiz Med Wochenschr; 1982 Oct; 112(42):1468-72. PubMed ID: 6755696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic nephropathy and renal transplantation.
    Schwarz A; Offermann G; Keller F
    Nephrol Dial Transplant; 1992; 7(5):427-32. PubMed ID: 1321379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.